- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Cost-Effective Interventions to Fight Childhood Obesity
When evaluating the cost-effectiveness of 4 different interventions to prevent or reduce childhood obesity, researchers found that the benefit of these interventions surpassed the current clinical interventions to treat obesity.
As the obesity epidemic continues to hound healthcare providers, policy makers, and the government, scientists are working to develop alternate models to prevent, rather than treat, the condition. A paper published in the July issue of the American Journal of Preventive Medicine evaluated the impact of 4 childhood obesity interventions: sugar-sweetened beverage excise tax (SSB), eliminating tax subsidy of TV advertising to children (TV AD), early care and education policy change (ECE), and active physical education (active PE).
The simulation model used in the study created a representative US population for a 10-year period between 2015 and 2025. The results of the simulated study showed that 3 of the 4 interventions would yield net savings: SSB, TV AD, and active PE. While SSB and TV AD would create tax revenue, they'd also avert disability-adjusted life years while improving quality-adjusted life years. These intervention, the authors write, are more cost-effective than current clinical interventions to treat obesity.
High HSP60 Expression Signals Poor Prognosis, Aggressive Tumors in Ovarian Cancer
January 16th 2025High heat shock protein 60 (HSP60) expression in patients with ovarian cancer is associated with larger tumors, advanced stages, and worse survival outcomes, highlighting its potential as a prognostic biomarker.
Read More
Real-World Evidence Confirms the Benefits of JAK Inhibitors in Patients With Rheumatoid Arthritis
January 16th 2025This systematic review of real-world observational studies demonstrated the effectiveness of Janus kinase (JAK) inhibitors in improving treatment adherence, persistence, clinical outcomes, and patient-reported outcomes among US patients with rheumatoid arthritis.
Read More
